| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2537.)
© 2003 American Heart Association, Inc.
Cochrane Corner |
From the Cochrane Stroke Group, Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.
Correspondence to Prof Peter A. Sandercock, University of Edinburgh, Dept of Clinical Neurosciences, Neurosciences Trial Unit, Western General Hospital, Crewe Rd, Edinburgh, EH4 2XU, UK. E-mail pags@skull.dcn.ed.ac.uk
Key Words: databases randomized controlled trials systematic review
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The Cochrane Collaboration1 is an international organization that aims to help people make well-informed decisions about health care by preparing, maintaining, and ensuring the accessibility of systematic reviews of the effects of health care interventions. In the early 1990s, there was clearly a need for systematic reviews in stroke,2 and so the Cochrane Stroke Group3 was set up and registered with the Cochrane Collaboration on August 1, 1993.
Aims
The goals of the Cochrane Stroke Group are as follows:
Methods
Protocols for reviews are prepared according to strict methodological guidelines and must be accepted for publication before work on the review can begin. Protocols and completed reviews are subject to extensive and rigorous peer review before publication (full details of Cochrane methods and Stroke Group specific methods are available in the Cochrane Handbook and the Stroke Groups Module, respectively, in the Cochrane Library).4
Progress Thus Far
Specialized Register of Trials
To find relevant
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |